Guangzhou Xianpeng Jinjian E-commerce Co., Ltd – Trademark Portfolio

Entity Type: 16

Guangzhou Xianpeng Jinjian E-commerce Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include BURJJIY. The owner is based in Guangzhou City.

Room 401, Building 1, No. 6, Yingxin

Guangzhou City 510000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

BURJJIY
BURJJIY
Registered 2023

Trademark Classifications

Guangzhou Xianpeng Jinjian E-commerce Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Guangzhou Xianpeng Jinjian E-commerce Co., Ltd have?

Guangzhou Xianpeng Jinjian E-commerce Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Guangzhou Xianpeng Jinjian E-commerce Co., Ltd file in?

Guangzhou Xianpeng Jinjian E-commerce Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Guangzhou Xianpeng Jinjian E-commerce Co., Ltd's most well-known trademarks?

Guangzhou Xianpeng Jinjian E-commerce Co., Ltd's registered trademark portfolio includes well-known marks such as BURJJIY. These are among 1 currently registered trademark in the portfolio.

What is Guangzhou Xianpeng Jinjian E-commerce Co., Ltd's trademark registration success rate?

Guangzhou Xianpeng Jinjian E-commerce Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.